Related references
Note: Only part of the references are listed.On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson's Disease
Olimpo Garcia-Beltran et al.
ANTIOXIDANTS (2023)
Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease
Joseph Nowell et al.
AGEING RESEARCH REVIEWS (2023)
Lecanemab: First Approval
Sheridan M. Hoy
DRUGS (2023)
Parkinson's disease: a never ending story
Heinz Reichmann et al.
JOURNAL OF NEURAL TRANSMISSION (2023)
New Pieces for an Old Puzzle: Approaching Parkinson's Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics
Lorena Ortega Moreno et al.
NUTRIENTS (2023)
Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review
Xiaoman Yang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2023)
The potential of the gut microbiome for identifying Alzheimer's disease diagnostic biomarkers and future therapies
Yu Zhan et al.
FRONTIERS IN NEUROSCIENCE (2023)
Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)
Marcos Tadashi Kakitani Toyoshima et al.
CLINICS (2023)
Administration of Human Derived Upper gut Commensal Prevotella histicola delays the onset of type 1 diabetes in NOD mice
Eric Marietta et al.
BMC MICROBIOLOGY (2022)
Advanced glycation end products in food and their effects on intestinal tract
Chenzhipeng Nie et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)
Glycated Albumin for the Diagnosis of Diabetes in US Adults
Michael Fang et al.
CLINICAL CHEMISTRY (2022)
Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes
Juraj Koska et al.
DIABETES CARE (2022)
Association between Helicobacter pylori infection and the risk of type 2 diabetes mellitus based on a middle-aged and elderly Chinese population
Jielin Zhou et al.
ENDOCRINE JOURNAL (2022)
The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
Matthew Snelson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer's Disease: The JPSC-AD
Moeko Noguchi-Shinohara et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Is dietary intake of advanced glycation end products associated with mortality among adults with diabetes?
Alain K. Koyama et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)
In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration
Marialena Chrysanthou et al.
NUTRIENTS (2022)
The activity of glyoxylase 1 is regulated by glucose-responsive phosphorylation on Tyr136
Fabiola Garcia Cortizo et al.
MOLECULAR METABOLISM (2022)
Dietary Advanced Glycation End Products Shift the Gut Microbiota Composition and Induce Insulin Resistance in Mice
Jiao Wang et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
Vincent M. Monnier et al.
BMJ OPEN DIABETES RESEARCH & CARE (2022)
Effects of an low carbohydrate/healthy fat/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson's disease: a pilot study
Melanie M. Tidman et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2022)
Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several C. elegans Strains Including a C. elegans Alzheimer's Disease Model
Joel Frandsen et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Hemoglobin glycation index predicts renal function deterioration in patients with type 2 diabetes and a low risk of chronic kidney disease
Chih-Hung Lin et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus
Md Tanvir Kabir et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)
Investigating the molecular mechanisms of glyoxal-induced cytotoxicity in human embryonic kidney cells: Insights from network toxicology and cell biology experiments
Dan Liu et al.
ENVIRONMENTAL TOXICOLOGY (2022)
Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
Jasvinder Singh Bhatti et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Biophysical changes in methylglyoxal modified fibrinogen and its role in the immunopathology of type 2 diabetes mellitus
Shahida Perween et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
Naila Rabbani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
Azad Farzadfard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Dietary Advanced Glycation End-Products Affects the Progression of Early Diabetes by Intervening in Carbohydrate and Lipid Metabolism
Yi Wu et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2022)
Diabetes, Glycated Hemoglobin (HbA1c), and Neuroaxonal Damage in Parkinson's Disease (MARK-PD Study)
Merve Uyar et al.
MOVEMENT DISORDERS (2022)
Rapamycin Pretreatment Attenuates High Glucose-induced Alteration of Synaptic Transmission in Hippocampal Dentate Gyrus Neurons
Tianyue Jiang et al.
NEUROSCIENCE (2022)
Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults
Michal Schnaider Beeri et al.
NUTRIENTS (2022)
Dietary Advanced Glycation End Products in an Elderly Population with Diabetic Nephropathy: An Exploratory Investigation
Mieke Steenbeke et al.
NUTRIENTS (2022)
Exploring the Causal Effect of Constipation on Parkinson's Disease Through Mediation Analysis of Microbial Data
Shih-Chen Fu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
Song Li et al.
FRONTIERS IN NEUROSCIENCE (2022)
Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions
Chenyin Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes
Ana Chegao et al.
NPJ PARKINSONS DISEASE (2022)
Sodium Ions Affect Pyrraline Formation in the Maillard Reaction With Lys-Containing Dipeptides and Tripeptides
Zhili Liang et al.
FRONTIERS IN NUTRITION (2022)
A Review of Electrochemical Sensors for the Detection of Glycated Hemoglobin
Zhikun Zhan et al.
BIOSENSORS-BASEL (2022)
Plasma glycation adducts and various RAGE isoforms are intricately associated with oxidative stress and inflammatory markers in type 2 diabetes patients with vascular complications
Krishna A. Adeshara et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)
Therapeutic Efficacy of Natural Product 'C-Phycocyanin' in Alleviating Streptozotocin-Induced Diabetes via the Inhibition of Glycation Reaction in Rats
Arbab Husain et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Glycation of α-synuclein hampers its binding to synaptic-like vesicles and its driving effect on their fusion
Ana Belen Uceda et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Methylglyoxal and glyoxalase 1-a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes
Naila Rabbani
CLINICAL SCIENCE (2022)
EGCG attenuates the neurotoxicity of methylglyoxal via regulating MAPK and the downstream signaling pathways and inhibiting advanced glycation end products formation
Yin He et al.
FOOD CHEMISTRY (2022)
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
Eric McDade et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease
Long Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Microtube Array Membrane Encapsulated Cell Therapy: A Novel Platform Technology Solution for Treatment of Alzheimer's Disease
Shu-Mei Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
DJ-1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons
Melissa Conti Mazza et al.
JOURNAL OF NEUROCHEMISTRY (2022)
The association between urinary pentosidine levels and cognition in drug-naive patients with Parkinson's disease
Shusaku Omoto et al.
NEUROLOGICAL SCIENCES (2022)
Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review
Abdullahi Tunde Aborode et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders
Nathan M. D'Cunha et al.
NUTRIENTS (2022)
Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer's Disease-Related Pathologies in Wild-Type Mice
Mona Abdelhamid et al.
NUTRIENTS (2022)
Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
Amelia K. Fotheringham et al.
NUTRIENTS (2022)
Correlation between Glycation-Related Biomarkers and Quality of Life in the General Japanese Population: The Iwaki Cross-Sectional Research Study
Masaya Tsubokawa et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Gut microbiota: A new target for T2DM prevention and treatment
Lulu Liu et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Diagnostic Performance of Sex-Specific Modified Metabolite Patterns in Urine for Screening of Prediabetes
Zaifang Li et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Therapeutic Potential of Quercetin in the Management of Type-2 Diabetes Mellitus
Prawej Ansari et al.
LIFE-BASEL (2022)
Advanced glycation end products induce Aβ1-42 deposition and cognitive decline through H19/miR-15b/BACE1 axis in diabetic encephalopathy
Lei Jiang et al.
BRAIN RESEARCH BULLETIN (2022)
Metformin encapsulated gold nanoparticles (MTF-GNPs): A promising antiglycation agent
Fahaad Alenazi et al.
CELL BIOCHEMISTRY AND FUNCTION (2022)
D-ribose-mediated glycation of fibrinogen: Role in the induction of adaptive immune response
Sultan Alouffi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
Glycation of Immunoglobulin-G from Pentose Sugar: A Cause for Structural Perturbations
Fahaad Alenazi et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2022)
Mineralocorticoid interaction with glycated albumin downregulates NRF-2 signaling pathway in renal cells: Insights into diabetic nephropathy
Deepesh D. Gaikwad et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies
Nilima S. Bangar et al.
GLYCOBIOLOGY (2022)
In vitro differentiation of human pancreatic duct-derived PANC-1 cells into β-cell phenotype using Tinospora cordifolia
Hemangee Damame et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2022)
Rapid pretreatment for multi-sample analysis of advanced glycation end products and their role in nephropathy
Sayuri Kato et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2022)
Food-Related Carbonyl Stress in Cardiometabolic and Cancer Risk Linked to Unhealthy Modern Diet
Carla Iacobini et al.
NUTRIENTS (2022)
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study
M. Piazza et al.
DIABETIC MEDICINE (2021)
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
Periyanaina Kesika et al.
LIFE SCIENCES (2021)
Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor
Gudrian Ricardo Lopes de Almeida et al.
MOLECULAR NEUROBIOLOGY (2021)
Glyoxal damages human aortic endothelial cells by perturbing the glutathione, mitochondrial membrane potential, and mitogen-activated protein kinase pathways
Ming-Zhang Xie et al.
BMC CARDIOVASCULAR DISORDERS (2021)
Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress
Firoz Akhter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
The Microbiota-Gut-Brain Axis: From Motility to Mood
Kara G. Margolis et al.
GASTROENTEROLOGY (2021)
Methylglyoxal affects cognitive behaviour and modulates RAGE and Presenilin-1 expression in hippocampus of aged mice
M. Pucci et al.
FOOD AND CHEMICAL TOXICOLOGY (2021)
Glycation of Host Proteins Increases Pathogenic Potential of Porphyromonas gingivalis
Michal Smiga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
Jinluan Chen et al.
JAMA NETWORK OPEN (2021)
Glycation of gut proteins initiates microbial dysbiosis and can promote establishment of diabetes in experimental animals
Rahul Patil et al.
MICROBIAL PATHOGENESIS (2021)
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease
Velma T. E. Aho et al.
MOLECULAR NEURODEGENERATION (2021)
Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease
Yan-fang Hou et al.
MICROBIOME (2021)
Protein glycation ? biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
Naila Rabbani et al.
REDOX BIOLOGY (2021)
Role of curd and yogurt in establishment and progression of diabetes through protein glycation and induction of inflammation
Rahul Patil et al.
FOOD BIOSCIENCE (2021)
Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease
Zongxin Ling et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Epigenetics of Alzheimer's Disease
Matea Nikolac Perkovic et al.
BIOMOLECULES (2021)
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano et al.
NPJ PARKINSONS DISEASE (2021)
Methylglyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Inflammation via Interaction with RAGE in Mesangial Cells
Hee-Weon Lee et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2021)
Elevated serum pentosidine is independently associated with the high prevalence of sarcopenia in Chinese middle-aged and elderly men with type 2 diabetes mellitus
Xiaofan Zhang et al.
JOURNAL OF DIABETES INVESTIGATION (2021)
Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
Kensei Taguchi et al.
TOXINS (2021)
Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts
Cecile Guillon et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Highland Barley and Its By-Products Enriched with Phenolic Compounds for Inhibition of Pyrraline Formation by Scavenging α-Dicarbonyl Compounds
Dianwei Zhang et al.
FOODS (2021)
Increased Added Sugar Consumption Is Common in Parkinson's Disease
Natalie C. Palavra et al.
FRONTIERS IN NUTRITION (2021)
Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)
Kumar B. Rajan et al.
ALZHEIMERS & DEMENTIA (2021)
Detecting beta-amyloid glycation by intrinsic fluorescence-Understanding the link between diabetes and Alzheimer's disease
Abeer Alghamdi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)
Carbonyl stress in diabetics with acute coronary syndrome
Sushmita Bora et al.
CLINICA CHIMICA ACTA (2021)
Understanding the Role of Protein Glycation in the Amyloid Aggregation Process
Ivana Sirangelo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Exploring the Impact of Glyoxal Glycation on β-Amyloid Peptide (Aβ) Aggregation in Alzheimer's Disease
Kai-Wei Hu et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2021)
Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration
Chenyin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques
Nicolo Bisi et al.
FRONTIERS IN CHEMISTRY (2021)
Role of Epigenetics in Type 2 Diabetes and Obesity
Rosanna Capparelli et al.
BIOMEDICINES (2021)
Plasma Methylglyoxal Levels Are Associated With Amputations and Mortality in Severe Limb Ischemia Patients With and Without Diabetes
Nordin M. J. Hanssen et al.
DIABETES CARE (2021)
Parkinson's disease and the gastrointestinal microbiome
Michal Lubomski et al.
JOURNAL OF NEUROLOGY (2020)
Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease
Kavya Jash et al.
DRUG DEVELOPMENT RESEARCH (2020)
Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model
Min-Soo Kim et al.
GUT (2020)
Glycated albumin
Mustapha Zendjabil
CLINICA CHIMICA ACTA (2020)
Butyrate modulates diabetes-linked gut dysbiosis: epigenetic and mechanistic modifications
Mohamed H. Noureldein et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2020)
Inhibition of GLUT2 transporter by geraniol from Cymbopogon martinii: a novel treatment for diabetes mellitus in streptozotocin-induced diabetic rats
Snehalata Prakash Kamble et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice
Jozimar Carlos Szczepanik et al.
NEUROCHEMICAL RESEARCH (2020)
Effect of Glyoxal Modification on a Critical Arginine Residue (Arg-31α) of Hemoglobin: Physiological Implications of Advanced Glycated End Product an In Vitro Study
Sauradipta Banerjee
PROTEIN AND PEPTIDE LETTERS (2020)
Bacillus Subtilis Delays Neurodegeneration and Behavioral Impairment in the Alzheimer's Disease Model Caenorhabditis Elegans
Sebastian Cogliati et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Gut, oral and nasal microbiota and Parkinson's disease
Liang Shen
MICROBIAL CELL FACTORIES (2020)
The Effect of Lactobacillus fermentum ME-3 Treatment on Glycation and Diabetes Complications
Axel Guilbaud et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2020)
Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung et al.
EBIOMEDICINE (2020)
Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans
Maria Eugenia Goya et al.
CELL REPORTS (2020)
Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease
Gurjit Kaur Bhatti et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein
Hugo Vicente Miranda et al.
FASEB JOURNAL (2020)
The Association between HbA1c Levels, Olfactory Memory and Cognition in Normal, Pre-Diabetic and Diabetic Persons
Burak Yulug et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
Kristine B. Holte et al.
PLOS ONE (2020)
Bifidobacteria shape host neural circuits during postnatal development by promoting synapse formation and microglial function
Berkley Luck et al.
SCIENTIFIC REPORTS (2020)
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease
Mihai S. Cirstea et al.
MOVEMENT DISORDERS (2020)
Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review
Larissa-Nele Schaffert et al.
BRAIN SCIENCES (2020)
Refined carbohydrate-rich diet is associated with long-term risk of dementia and Alzheimer's disease in apolipoprotein E ε4 allele carriers
Melissa Gentreau et al.
ALZHEIMERS & DEMENTIA (2020)
Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
Federico Baldini et al.
BMC BIOLOGY (2020)
Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease
Amit Sharma et al.
REDOX BIOLOGY (2020)
The Role of Glycation on the Aggregation Properties of IAPP
Giulia Milordini et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Generation and Characterization of Anti-Glucosepane Antibodies Enabling Direct Detection of Glucosepane in Retinal Tissue
Matthew D. Streeter et al.
ACS CHEMICAL BIOLOGY (2020)
Meta-Analysisof Gut Dysbiosis in Parkinson's Disease
Hiroshi Nishiwaki et al.
MOVEMENT DISORDERS (2020)
Probiotics ameliorate intestinal pathophysiology in a mouse model of Alzheimer’s disease
Harpreet Kaur et al.
NEUROBIOLOGY OF AGING (2020)
RAGE and its ligands: from pathogenesis to therapeutics
Nitish Jangde et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
Bruce A. Perkins et al.
SCIENTIFIC REPORTS (2020)
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: the Receptor for Advanced Glycation End Products (RAGE)
Yanyan Kong et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease
Moira Marizzoni et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Urinary cathepsin L is predictive of changes in albuminuria and correlates with glucosepane in patients with type 2 diabetes in a closed-cohort study
Sebastian Brings et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
Helicobacter pyloriEradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial
Ai Huey Tan et al.
MOVEMENT DISORDERS (2020)
An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease
Raffaella Nativio et al.
NATURE GENETICS (2020)
Epigenomic analysis of Parkinson's disease neurons identifies Tet2 loss as neuroprotective
Lee L. Marshall et al.
NATURE NEUROSCIENCE (2020)
Characterization of the intestinal microbiota duringCitrobacter rodentiuminfection in a mouse model of infection-triggered Parkinson's disease
Tyler Cannon et al.
GUT MICROBES (2020)
Synergy Effects of Metformin and Berberine on Glyoxal-induced Carbonyl Stress in Isolated Rat Liver Mitochondria
Mohsen Rezaei et al.
CURRENT DRUG THERAPY (2020)
In vitro model using cytokine cocktail to evaluate apoptosis in Min6 pancreatic beta cells
Hemangee H. Damame et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Unravelling the effect of N(ε)-(carboxyethyl)lysine on the conformation, dynamics and aggregation propensity of α-synuclein
Laura Marino et al.
CHEMICAL SCIENCE (2020)
Sex specific cognitive differences in Parkinson disease
Tyler Harrison Reekes et al.
NPJ PARKINSONS DISEASE (2020)
Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study
Krishna A. Adeshara et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide
Yunxiang Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Early metabolic changes in the gut leads to higher expression of intestinal alpha glucosidase and thereby causes enhanced postprandial spikes
Megha L. Nalawade et al.
LIFE SCIENCES (2019)
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
D. Allan Butterfield et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Entanglement of Genetics and Epigenetics in Parkinson's Disease
H. J. van Heesbeen et al.
FRONTIERS IN NEUROSCIENCE (2019)
Nitration and Glycation Diminish the α-Synuclein Role in the Formation and Scavenging of Cu2+-Catalyzed Reactive Oxygen Species
Humberto Martinez-Orozco et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Methylglyoxal - An emerging biomarker for diabetes mellitus diagnosis and its detection methods
Lakshmishri Ramachandra Bhat et al.
BIOSENSORS & BIOELECTRONICS (2019)
Glycation of α-synuclein amplifies the binding with glyceraldehyde-3-phosphate dehydrogenase
Pavel Semenyuk et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Site-specific glycation of A1-42 affects fibril formation and is neurotoxic
Jin Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Acceleration of protein glycation by oxidative stress and comparative role of antioxidant and protein glycation inhibitor
Laxman N. Bavkar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
The role of short-chain fatty acids in microbiota-gut-brain communication
Boushra Dalile et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Do your gut microbes affect your brain dopamine?
Camila Gonzalez-Arancibia et al.
PSYCHOPHARMACOLOGY (2019)
Probiotics in Extraintestinal Diseases: Current Trends and New Directions
Despoina E. Kiousi et al.
NUTRIENTS (2019)
More Research Is Needed on Lifestyle Behaviors That Influence Progression of Parkinson's Disease
Nupur Nag et al.
FRONTIERS IN NEUROLOGY (2019)
Methylglyoxal induces glycation and oxidative stress in Saccharomyces cerevisiae
Rashmi S. Tupe et al.
ANNALS OF MICROBIOLOGY (2019)
Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease
Mohamed Haddad et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Fecal microbiota transplantation to treat Parkinson's disease with constipation A case report
Hongli Huang et al.
MEDICINE (2019)
Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice
Diana Matheoud et al.
NATURE (2019)
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Clara Depommier et al.
NATURE MEDICINE (2019)
Microbiome and type 1 diabetes
Heli Siljander et al.
EBIOMEDICINE (2019)
Inhibition of the receptor for advanced glycation inhibits lipopolysaccharide-mediated High mobility group protein B1 and Interleukin-6 synthesis in human gingival fibroblasts through the NF-κB signaling pathway
Jialin Huang et al.
ARCHIVES OF ORAL BIOLOGY (2019)
A Narrative Review of Lifestyle Factors Associated with Parkinson's Disease Risk and Progression
Nupur Nag et al.
NEURODEGENERATIVE DISEASES (2019)
The gut microbiota: A novel therapeutic target in Parkinson's disease?
Michal Lubomski et al.
PARKINSONISM & RELATED DISORDERS (2019)
Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP/PS1 transgenic mice
Jing Sun et al.
TRANSLATIONAL PSYCHIATRY (2019)
Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease
Agata Mulak et al.
FRONTIERS IN NEUROSCIENCE (2019)
Methylglyoxal and Glyoxal as Potential Peripheral Markers for MCI Diagnosis and Their Effects on the Expression of Neurotrophic, Inflammatory and Neurodegenerative Factors in Neurons and in Neuronal Derived-Extracellular Vesicles
Mohamed Haddad et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Glucoselysine is derived from fructose and accumulates in the eye lens of diabetic rats
Rei-ichi Ohno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Review of Biguanide (Metformin) Toxicity
George Sam Wang et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2019)
TET2 Regulates the Neuroinflammatory Response in Microglia
Alejandro Carrillo-Jimenez et al.
CELL REPORTS (2019)
Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences
Domenico Sergi et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiome
Dora Abraham et al.
EXPERIMENTAL GERONTOLOGY (2019)
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Michela Barichella et al.
MOVEMENT DISORDERS (2019)
Brain-Gut-Microbiota Axis in Alzheimer's Disease
Karol Kowalski et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Diet in Parkinson's Disease: Critical Role for the Microbiome
Aeja Jackson et al.
FRONTIERS IN NEUROLOGY (2019)
Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications
Lijuan Zhao et al.
ENDOCRINE (2019)
Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease
Kedar Batkulwar et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Lactobacilli and bifidobacteria ameliorate memory and learning deficits and oxidative stress in β-amyloid (1-42) injected rats
Somayeh Athari Nik Azm et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2018)
HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
Fanfan Zheng et al.
DIABETOLOGIA (2018)
Aberrant intestinal microbiota in individuals with prediabetes
Kristine H. Allin et al.
DIABETOLOGIA (2018)
Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment
W. Kleinherenbrink et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting the TLR/NF-kappa B Pathway
Bingyu Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes
R. P. Settem et al.
MOLECULAR ORAL MICROBIOLOGY (2018)
Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial
Joaquin A. Vizcarra et al.
PARKINSONISM & RELATED DISORDERS (2018)
Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease
Andreas Schwiertz et al.
PARKINSONISM & RELATED DISORDERS (2018)
Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study
Huei-Kai Huang et al.
PARKINSONISM & RELATED DISORDERS (2018)
Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice
Jin Gyu Choi et al.
SCIENTIFIC REPORTS (2018)
Gene Therapy for Parkinson's Disease, An Update
Tobias M. Axelsen et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease
Paula A. Q. Videira et al.
FRONTIERS IN NEUROSCIENCE (2018)
Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice
Yang Xin et al.
FRONTIERS IN NEUROLOGY (2018)
The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality
Jyotiska Chaudhuri et al.
CELL METABOLISM (2018)
Pioglitazone inhibits advanced glycation induced protein modifications and down-regulates expression of RAGE and NF-κB in renal cells
Krishna A. Adeshara et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study
Mee Kyoung Kim et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2018)
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Delphine Charvin et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Current surgical treatments for Parkinson's disease and potential therapeutic targets
Darrin J. Lee et al.
NEURAL REGENERATION RESEARCH (2018)
Parkinson's disease and bacteriophages as its overlooked contributors
George Tetz et al.
SCIENTIFIC REPORTS (2018)
Effects of Transcranial Direct Current Stimulation (tDCS) Over the Frontal Polar Area on Motor and Executive Functions in Parkinson's Disease; A Pilot Study
Koji Ishikuro et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Helicobacter pylori Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
Yan Shi et al.
CHINESE MEDICAL JOURNAL (2018)
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
Tommi Vatanen et al.
NATURE (2018)
Levodopa-induced dyskinesia in Parkinson disease A population-based cohort study
Pierpaolo Turcano et al.
NEUROLOGY (2018)
Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's Disease, Alzheimer's Disease and Type 2 Diabetes Mellitus
Greta M. de Waal et al.
SCIENTIFIC REPORTS (2018)
Effect of intensive lifestyle modification & metformin on cardiovascular risk in prediabetes: A pilot randomized control trial
Shruthi Kulkarni et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2018)
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration
Timothy G. Dinan et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Inflammatory Response in the CNS: Friend or Foe?
Marta Sochocka et al.
MOLECULAR NEUROBIOLOGY (2017)
Human gut microbiota: the links with dementia development
Rashad Alkasir et al.
PROTEIN & CELL (2017)
Effective inhibition of protein glycation by combinatorial usage of limonene and aminoguanidine through differential and synergistic mechanisms
Madhav M. Joglekar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
Liang Shen et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model
Carolin Brandscheid et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota
Silvia Pellegrini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Relationship between plasma glycation with membrane modification, oxidative stress and expression of glucose trasporter-1 in type 2 diabetes patients with vascular complications
Krishna A. Adeshara et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury
Wan-Ju Yeh et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Methylglyoxal attenuates insulin signaling and downregulates the enzymes involved in cholesterol biosynthesis
Arati B. Deshmukh et al.
MOLECULAR BIOSYSTEMS (2017)
Past, Present, and Future of Parkinson's Disease: A Special Essay on the 200th Anniversary of the Shaking Palsy
J. A. Obeso et al.
MOVEMENT DISORDERS (2017)
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
Annamaria Cattaneo et al.
NEUROBIOLOGY OF AGING (2017)
Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
Eduardo Lattari et al.
NEUROSCIENCE LETTERS (2017)
Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy
Cheng Li et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila
Shih-Cheng Wu et al.
NATURE COMMUNICATIONS (2017)
Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation
Juciano Gasparotto et al.
SCIENTIFIC REPORTS (2017)
16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain
David C. Emery et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
The role of microbial amyloid in neurodegeneration
Robert P. Friedland et al.
PLOS PATHOGENS (2017)
Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus
Yuhai Zhao et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit
Abolghasem Tohidpour et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases
Xuan Li et al.
FRONTIERS IN IMMUNOLOGY (2017)
Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer's Disease Brain
Yuhai Zhao et al.
FRONTIERS IN IMMUNOLOGY (2017)
Host-Microbiota Mutualism in Metabolic Diseases
Salvatore Fabbiano et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
T. Harach et al.
SCIENTIFIC REPORTS (2017)
Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels
Laura Bonfili et al.
SCIENTIFIC REPORTS (2017)
Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses
Leonardo Mancabelli et al.
SCIENTIFIC REPORTS (2017)
Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer's disease
Myles R. Minter et al.
SCIENTIFIC REPORTS (2017)
Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease
Yodai Kobayashi et al.
SCIENTIFIC REPORTS (2017)
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Eamonn M. M. Quigley
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Cell Therapy for Parkinson's Disease
Takao Yasuhara et al.
CELL TRANSPLANTATION (2017)
Dietary habits and neurological features of Parkinson's disease patients: Implications for practice
Michela Barichella et al.
CLINICAL NUTRITION (2017)
Metformin Use in Prediabetes Among US Adults, 2005-2012
Eva Tseng et al.
DIABETES CARE (2017)
Posttranslational modification impact on the mechanism by which amyloid-β induces synaptic dysfunction
Katarzyna M. Grochowska et al.
EMBO REPORTS (2017)
Dynamics of diabetes and obesity: Epidemiological perspective
Annette Boles et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
Hugo Vicente Miranda et al.
BRAIN (2017)
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Subbiah Pugazhenthi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal
Ramesh Kandimalla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Analysis of Gut Microbiota in Patients with Parkinson's Disease
V. A. Petrov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Inflammaging decreases adaptive and innate immune responses in mice and humans
Daniela Frasca et al.
BIOGERONTOLOGY (2016)
Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes
Adil Mardinoglu et al.
CELL METABOLISM (2016)
The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease
Cristiano A. Kohler et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes
Krishna Adeshara et al.
MOLECULAR BIOLOGY REPORTS (2016)
Glycation in Parkinson's Disease and Alzheimer's Disease
Hugo Vicente Miranda et al.
MOVEMENT DISORDERS (2016)
Human gut microbes impact host serum metabolome and insulin sensitivity
Helle Krogh Pedersen et al.
NATURE (2016)
Diet-microbiota interactions as moderators of human metabolism
Justin L. Sonnenburg et al.
NATURE (2016)
Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice
Vivian M. Choi et al.
NATURE MEDICINE (2016)
Gram-negative bacterial molecules associate with Alzheimer disease pathology
Xinhua Zhan et al.
NEUROLOGY (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Marcus M. Unger et al.
PARKINSONISM & RELATED DISORDERS (2016)
Glycation induces conformational changes in the amyloid-β peptide and enhances its aggregation propensity: molecular insights
Asis K. Jana et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Exposing the exposures responsible for type 2 diabetes and obesity
Paul W. Franks et al.
SCIENCE (2016)
Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease
Deepak Kumar Vijaya Kumar et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
Yuli Huang et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
Yuli Huang et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Human Intestinal Barrier Function in Health and Disease
Julia Konig et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Gut microbiota and immune crosstalk in metabolic disease
Remy Burcelin
MOLECULAR METABOLISM (2016)
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
Baohong Wang et al.
SCIENTIFIC REPORTS (2016)
Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
Shu G. Chen et al.
SCIENTIFIC REPORTS (2016)
Potential role of antimicrobial peptides in the early onset of Alzheimer's disease
Mick M. Welling et al.
ALZHEIMERS & DEMENTIA (2015)
Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012 A Retrospective Cohort Study
Tannaz Moin et al.
ANNALS OF INTERNAL MEDICINE (2015)
Effects of Diurnal Variation of Gut Microbes and High-Fat Feeding on Host Circadian Clock Function and Metabolism
Vanessa Leone et al.
CELL HOST & MICROBE (2015)
Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling
Robert Caesar et al.
CELL METABOLISM (2015)
Zinc inhibits glycation induced structural, functional modifications in albumin and protects erythrocytes from glycated albumin toxicity
Rashmi Tupe et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
Elevated fecal calprotectin in patients with Alzheimer's dementia indicates leaky gut
Friedrich Leblhuber et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2 antioxidant signaling pathways
Rania M. Abdelsalam et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease
Giuseppe Verdile et al.
MEDIATORS OF INFLAMMATION (2015)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans
B. A. Martinez et al.
CELL DEATH & DISEASE (2015)
Dietary Factors in the Etiology of Parkinson's Disease
Zeynep S. Agim et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
David M. Nathan
LANCET DIABETES & ENDOCRINOLOGY (2015)
The composition of the gut microbiota shapes the colon mucus barrier
Hedvig E. Jakobsson et al.
EMBO REPORTS (2015)
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease
Satoru Hasegawa et al.
PLOS ONE (2015)
Prediabetes diagnosis and treatment: A review
Nidhi Bansal
WORLD JOURNAL OF DIABETES (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Robert P. Friedland
JOURNAL OF ALZHEIMERS DISEASE (2015)
The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade
Chao Wang et al.
ACTA NEUROPATHOLOGICA (2014)
Dicarbonyl proteome and genome damage in metabolic and vascular disease
Naila Rabbani et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Intestinal permeability - a new target for disease prevention and therapy
Stephan C. Bischoff et al.
BMC GASTROENTEROLOGY (2014)
Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
Julio C. Tobon-Velasco et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Myricitrin Alleviates Methylglyoxal-Induced Mitochondrial Dysfunction and AGEs/RAGE/NF-κB Pathway Activation in SH-SY5Y Cells
Yue-Hua Wang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
Katie Lunnon et al.
NATURE NEUROSCIENCE (2014)
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci
Philip L. De Jager et al.
NATURE NEUROSCIENCE (2014)
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease
Neal D. Barnard et al.
NEUROBIOLOGY OF AGING (2014)
Small intestinal bacterial overgrowth in Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2014)
Helicobacter pylori Induced Gastric Immunopathology Is Associated with Distinct Microbiota Changes in the Large Intestines of Long-Term Infected Mongolian Gerbils
Markus M. Heimesaat et al.
PLOS ONE (2014)
Advanced glycation end products, dementia, and diabetes
Simon Lovestone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Role of Methylglyoxal in Alzheimer's Disease
Cristina Angeloni et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship
Nicholas T. Vagelatos et al.
EPIDEMIOLOGIC REVIEWS (2013)
alpha-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment
Ane Korff et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
A novel mechanism for antiglycative action of limonene through stabilization of protein conformation
Madhav M. Joglekar et al.
MOLECULAR BIOSYSTEMS (2013)
Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson's Disease
Erika Guerrero et al.
MOLECULAR NEUROBIOLOGY (2013)
The role of small intestinal bacterial overgrowth in Parkinson's disease
Alfonso Fasano et al.
MOVEMENT DISORDERS (2013)
Richness of human gut microbiome correlates with metabolic markers
Emmanuelle Le Chatelier et al.
NATURE (2013)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer's Disease
Niklas K. U. Koehler et al.
PLOS ONE (2013)
Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer's Disease
Niklas Mattsson et al.
PLOS ONE (2013)
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Amandine Everard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Vanessa K. Ridaura et al.
SCIENCE (2013)
Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration
V. Hugh Perry et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
The Role of Oxidative Stress in Parkinson's Disease
Vera Dias et al.
JOURNAL OF PARKINSONS DISEASE (2013)
Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)
Tomoaki Uchiki et al.
AGING CELL (2012)
Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse
Marielle S. Kahn et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in Parkinsonian brains
Yulin Deng et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia
Ursula Puentener et al.
JOURNAL OF NEUROINFLAMMATION (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results
Claire Roubaud-Baudron et al.
NEUROBIOLOGY OF AGING (2012)
Genetics and Epigenetics of Parkinson's Disease
Fabio Coppede
SCIENTIFIC WORLD JOURNAL (2012)
Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
William M. Johnson et al.
NUTRIENTS (2012)
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
Alexander Kurz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
Melinda T. Coughlan et al.
DIABETES (2011)
Peripheral Vascular Disease and Peripheral Neuropathy in Individuals With Cardiometabolic Clustering and Obesity National Health and Nutrition Examination Survey 2001-2004
Kelly R. Ylitalo et al.
DIABETES CARE (2011)
Role of Chronic and Acute Hyperglycemia in the Development of Diabetes Complications
M. Loredana Marcovecchio et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Gastric and Duodenum Microflora Analysis After Long-Term Helicobacter pylori Infection in Mongolian Gerbils
Ya-Ni Yin et al.
HELICOBACTER (2011)
Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease
Maurizio Gabrielli et al.
MOVEMENT DISORDERS (2011)
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam et al.
NATURE (2011)
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Velandai Srikanth et al.
NEUROBIOLOGY OF AGING (2011)
Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study
Emma Aden et al.
NUTRITIONAL NEUROSCIENCE (2011)
High fat diet induced diabetic cardiomyopathy
Ellen Dirkx et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Nε-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model
Yeong-Gon Choi et al.
BIOCHIMIE (2010)
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Gavin I. Welsh et al.
CELL METABOLISM (2010)
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
Hillary A. Keenan et al.
DIABETES (2010)
Are Certain Lifestyle Habits Associated with Lower Alzheimer's Disease Risk?
Lana Arab et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
Aileen M. Moloney et al.
NEUROBIOLOGY OF AGING (2010)
Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus
Tony Valente et al.
NEUROBIOLOGY OF DISEASE (2010)
Fermented milk of Lactobacillus helveticus IDCC3801 reduces beta-amyloid and attenuates memory deficit
Seung-Woo Yeon et al.
JOURNAL OF FUNCTIONAL FOODS (2010)
The modification of α-synuclein by dicarbonyl compounds inhibits its fibril-forming process
Daekyun Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Adults with type 1 diabetes eat a high-fat atherogenic diet that is associated with coronary artery calcium
J. K. Snell-Bergeon et al.
DIABETOLOGIA (2009)
Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer's Disease
Jannis Kountouras et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2009)
RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-beta-Induced Cellular Perturbation?
Shi Du Yan et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)
Rongzhen Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Arne Astrup et al.
LANCET (2009)
Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats
Peter Boor et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Peter J. Turnbaugh et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs
Angela Cassese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Advanced glycation end products induce in vitro cross-linking of α-synuclein and accelerate the process of intracellular inclusion body formation
Shamim Shaikh et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Prospective study of dietary pattern and risk of Parkinson disease
Xiang Gao et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Reduced expression of insulin receptors in the kidneys of insulin-resistant rats
Swasti Tiwari et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
High-fat diet-induced neuropathy of pre-diabetes and obesity - Effects of healthy diet and aldose reductase inhibition
Irina G. Obrosova et al.
DIABETES (2007)
Microbial ecology - Human gut microbes associated with obesity
Ruth E. Ley et al.
NATURE (2006)
Protein intake in parkinsonian patients using the EPIC food frequency questionnaire
Agnieszka Marczewska et al.
MOVEMENT DISORDERS (2006)
The gut flora as a forgotten organ
Ann M. O'Hara et al.
EMBO REPORTS (2006)
Metagenomic analysis of the human distal gut microbiome
Steven R. Gill et al.
SCIENCE (2006)
Relationship between Helicobacter pylori infection and Alzheimer disease
J Kountouras et al.
NEUROLOGY (2006)
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus
GJ Biessels et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
Ecological and evolutionary forces shaping microbial diversity in the human intestine
RE Ley et al.
CELL (2006)
Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis
G Dahlquist
DIABETOLOGIA (2006)
Risk of dementia in diabetes mellitus: a systematic review
GJ Biessels et al.
LANCET NEUROLOGY (2006)
The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats
I Cherny et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Compromised arterial function in human type 2 diabetic patients
EB Okon et al.
DIABETES (2005)
Albumin antioxidant capacity is modified by methylglyoxal
P Faure et al.
DIABETES & METABOLISM (2005)
Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains
HJ Lüth et al.
CEREBRAL CORTEX (2005)
Oxidative stress in childhood - in health and disease states
E Granot et al.
CLINICAL NUTRITION (2004)
Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats
XX Wang et al.
KIDNEY INTERNATIONAL (2004)
High carbohydrate diets and Alzheimer's disease
ST Henderson
MEDICAL HYPOTHESES (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Dietary fats and the risk of incident Alzheimer disease
MC Morris et al.
ARCHIVES OF NEUROLOGY (2003)
Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal
RH Nagaraj et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism
LF Lue et al.
EXPERIMENTAL NEUROLOGY (2001)
Advanced glycation end-products: a review
R Singh et al.
DIABETOLOGIA (2001)
Crosslinking of α-synuclein by advanced glycation endproducts -: an early pathophysiological step in Lewy body formation?
G Münch et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2000)
Amyloid in human islets of langerhans: Immunologic evidence that islet amyloid polypeptide is modified in amyloidogenesis
Z Ma et al.
PANCREAS (2000)
LPS-induced neuroinflammatory effects do not recover with time
B Hauss-Wegrzyniak et al.
NEUROREPORT (2000)
Plaque-associated α-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein
FS Yang et al.
BRAIN RESEARCH (2000)
Detection of an Amadori product, 1-hexitol-lysine, in the anterior horn of the amyotrophic lateral sclerosis and spinobulbar muscular atrophy spinal cord: evidence for early involvement of glycation in motoneuron diseases
S Kikuchi et al.
ACTA NEUROPATHOLOGICA (2000)